Опыт применения иммуномодулятора дезоксирибонуклеата натрия в лечении реактивного артрита хламидийной этиологии у детей

RESEARCHERS COMPARED EFFICACY OF THE CONVENTIONAL THERAPY (OIL-MENT WITH NONSTERIOD ANTIINFLAMMATORY MEDICATION, DICLOFENAC SODIUM AND AZITHROMYCIN) AMONG CHILDREN WITH REACTIVE ARTHRITIS OF CHLAMYDIA AETIOLOGY AND TREATMENT WITH INTRODUCTION OF GLU-COSAMINILMURAMILDIPEPTIDE AND DESOXIRIBONUCLEATE SODIUM IMMUNOMODULATORS. THE ARTICLE SHOWS THAT APPLICATION OF IMMUNOMODULATORS IN COMBINATION WITH THE CONVENTIONAL THERAPY PROVIDED FOR THE DECREASE OF THE ARTICULAR SYNDROME INTENSITY, REDUCED THE NEED OF THE PATIENTS IN LOCAL CORTICOSTEROIDS AND CONDUCED TO THE REDUCTION OF THE LAB PROCESS ACTIVITY INDICES. FURTHERMORE, THEY NOTICED REDUCED RECURRENCE OF THE ANTIBODIES TO CHLAMYDIAS AND THEIR TITERS IN THE BLOOD SERUM, WHILE GENERAL INTENSITY OF THE ANTIINFLAMMATORY EFFECTS FROM THE COMBINED THERAPY, WHICH INCLUDED GLUCOSAMINILMURAMILDIPEPTIDE AND DESOXIRIBONUCLEATE SODIUM IMMUNOMODULATORS ALONG WITH THE ANTIBIOTIC, PROVED TO BE COMPARABLE.